Cardinal Health, Inc. (CAH) Financials
Key financial figures for Cardinal Health, Inc. (Q4 2026).
Cardinal Health beat with Q4 FY2026 revenue up 6% to $63.7B and GAAP diluted EPS up 70% to $1.70, while guiding FY2027 non-GAAP EPS growth of 13-15%. Q4 FY2026 revenue rose 6% year over year to $63.7 billion; GAAP operating earnings jumped 70% to $729 million and GAAP diluted EPS rose 70% to $1.70. Non-GAAP diluted EPS increased 40% to $2.91, boosted by a one-time $0.31 IEEPA tariff refund; excluding that item, non-GAAP diluted EPS grew 25% to $2.60. Pharmaceutical and Specialty Solutions segment revenue grew 6% to $58.8 billion with segment profit up 21% to $645 million. Global Medical Products and Distribution segment profit more than doubled to $150 million (from $70 million a year ago) on a 2% revenue decline to $3.1 billion. On the outlook: Cardinal Health issued fiscal year 2027 non-GAAP diluted EPS guidance of 13-15% growth ($12.40 to $12.60 per share), above its long-term EPS guidance range; segment guidance includes Pharmaceutical and Specialty Solutions revenue growth of 3-5% and segment profit growth of 8-11%, Global Medical Products and Distribution revenue growth of 2-4% and segment profit of $200-220 million, and Other segment (NPHS, at-Home Solutions, OptiFreight Logistics) revenue growth of 11-13% and segment profit growth of 15-18%. Figures are for Q4 FY2026, as Cardinal Health, Inc. reported them.
- Total Assets
- $57.3B
- Operating Cash Flow
- $1.7B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q4 FY2026 | $63.9B | $394M | $1.69 | 1.14% | $1.4B |
| Q3 FY2026 | $60.9B | $399M | $1.69 | 0.84% | $1.7B |
| Q2 FY2026 | $65.4B | $471M | $1.97 | 1.08% | $555M |
| Q1 FY2026 | $64.0B | $450M | $1.88 | 1.04% | $865M |
| Q4 FY2025 | $60.2B | $239M | $1.00 | 0.71% | $1.3B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $254.2B | $1.7B | $7.23 | 1.03% | $4.5B |
| FY2025 | $222.6B | $1.6B | $6.45 | 1.02% | $1.9B |
| FY2024 | $226.8B | $852M | $3.45 | 0.55% | $3.3B |
Frequently asked questions
What was Cardinal Health, Inc.'s revenue last quarter?
Cardinal Health, Inc. reported revenue of $63.86 billion for Q4 FY2026, up 6.1% from the same period a year earlier.
Is Cardinal Health, Inc. profitable?
Yes. Cardinal Health, Inc. reported net income of $394.0 million for Q4 FY2026, a net margin of 0.62% on revenue.
How has Cardinal Health, Inc.'s margin trended?
Operating margin was 1.14% in Q4 FY2026, compared with 0.71% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Cardinal Health, Inc. generate?
Cardinal Health, Inc. generated free cash flow of $1.43 billion in Q4 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Cardinal Health, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.